We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice.
- Authors
Mormile, Mauro; Mormile, Ilaria; Fuschillo, Salvatore; Rossi, Francesca Wanda; Lamagna, Laura; Ambrosino, Pasquale; de Paulis, Amato; Maniscalco, Mauro
- Abstract
Eosinophils play a key role in airway inflammation in many diseases, such as allergic and non-allergic asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. In these chronic disabling conditions, eosinophils contribute to tissue damage, repair, remodeling, and disease persistence through the production a variety of mediators. With the introduction of biological drugs for the treatment of these respiratory diseases, the classification of patients based on clinical characteristics (phenotype) and pathobiological mechanisms (endotype) has become mandatory. This need is particularly evident in severe asthma, where, despite the great scientific efforts to understand the immunological pathways underlying clinical phenotypes, the identification of specific biomarkers defining endotypes or predicting pharmacological response remains unsatisfied. In addition, a significant heterogeneity also exists among patients with other airway diseases. In this review, we describe some of the immunological differences in eosinophilic airway inflammation associated with severe asthma and other airway diseases and how these factors might influence the clinical presentation, with the aim of clarifying when eosinophils play a key pathogenic role and, therefore, represent the preferred therapeutic target.
- Subjects
CHRONIC obstructive pulmonary disease; DISABILITIES; RESPIRATORY diseases; SYMPTOMS; THERAPEUTICS; NASAL mucosa
- Publication
International Journal of Molecular Sciences, 2023, Vol 24, Issue 8, p7254
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms24087254